Acute myocardial infarction in a young male on methylphenidate, bupropion, and erythromycin.
The prevalence and treatment of behavioral and mental illnesses in the adolescent population are increasing, and many of the medications used are continued into adulthood. Increased vigilance is necessary when caring for this population to prevent side effects and drug interactions. In this short communication, we present a case of myocardial infarction in a male likely related to drug interactions between bupropion, erythromycin, and methylphenidate.
George
Anil K
AK
Department of Medicine, SUNY Upstate Medical University, Syracuse, New York 13210, USA.
Kunwar
Arun R
AR
Awasthi
Ashish
A
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D016642:Bupropion / Q000009:adverse effects*; D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D004347:Drug Interactions; D004562:Electrocardiography / Q000187:drug effects; D004917:Erythromycin / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000009:adverse effects*; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000473:pathology
D000900:Anti-Bacterial Agents; D018687:Antidepressive Agents, Second-Generation; D000697:Central Nervous System Stimulants; D016642:Bupropion; D008774:Methylphenidate; D004917:Erythromycin